New Mexico Software PACS gains 510(k) clearance

TriMed Staff | | Health Imaging | Practice Management
New Mexico Software, a services provider of business and medical products, has obtained a 510(k) clearance from the FDA for its XR-EXpress PACS.

XR-EXpress PACS is a teleradiology system designed to retrieve HIPAA-compliant medical images in DICOM format, according to the Albuquerque, N.M.-based company. Also, the system generates, organizes and archives textual reports while making them accessible across web networks with customized user interfaces.

The company said its XR-EXpress will be targeted to hospitals, imaging centers, nursing homes, radiology reading practices and authorized users who require patients’ images, demographics and report information. FDA classified XR-EXpress as a Class II device under Regulation 21 CFR 892.2050 with product code LLZ.

TriMed Staff

Related Content

Newly launched report feature provides patients with a visual aid to their imaging
Center for Devices and Radiological Health hit with federal job cuts
Overview of the regulatory landscape of AI in radiology
Concerns about private equity's growing influence in radiology
'Ad hoc' shifts and radiology 'maestros': How one department addressed its workflow hiccups
Not all lead glasses are created equal

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.